How To Build An Exceptional Medical Device Biocompatibility Program meddeviceonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from meddeviceonline.com Daily Mail and Mail on Sunday newspapers.
SANTA CLARA, Calif., July 21, 2021 /PRNewswire/ Axon Therapies, a private company focused on addressing a root cause of heart failure, today announced the appointment of seasoned medical device executive Chad Hoskins as Chief Executive Officr (CEO). Mr. Hoskins will lead the company as it transitions from early development towards regulatory clearance and commercialization of its novel heart failure treatment, splanchnic ablation for volume management (SAVM), using the Satera™ Ablation System. Axon is poised to disrupt the heart failure market by treating a root cause of the disease rather than simply addressing patient symptoms. We are very pleased with our initial data demonstrating the potential of SAVM to improve the quality of life of heart failure patients with preserved ejection fraction, commented Howard Levin, MD, Co-founder of Axon Therapies and Deerfield Catalyst, a medtech innovation hub. Chad s deep understanding of the heart failure market and proven leade
Axon Therapies Announces Chad Hoskins As Chief Executive Officer prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
MCRA Expands its Cardiovascular Division, Hiring Fernando Aguel, Former Assistant Division Director, FDA Circulatory Support Devices
News provided by
Share this article
Share this article
WASHINGTON, May 20, 2021 /PRNewswire/ MCRA, LLC, a leading medical device and biologics advisory firm and clinical research organization (CRO) integrating US and International Regulatory, Clinical Research, Reimbursement, Healthcare Compliance, and Quality Assurance, is pleased to announce the hiring of Fernando Aguel as Vice President, Heart Failure & Circulatory Support Regulatory Affairs. Fernando previously served as U.S. Food and Drug Administration (FDA) Assistant Division Director, Circulatory Support Devices Team. MCRA s Cardio division continues to expand its expertise across all product areas in the cardiovascular space to provide clients with expert regulatory guidance, clinical study design and clinical trial execution.
Basil Systems Launches Commercial Platform While Securing $1.5M in Seed Funding
Share Article BOSTON (PRWEB) March 16, 2021 Basil Systems publicly released the commercial version of its SaaS platform while announcing the company’s first funding round which will be used to accelerate growth. Basil is a healthcare-focused start-up delivering a comprehensive system for the medical device and pharmaceutical industries, helping companies deliver safe and innovative products to patients and consumers, while reducing the time to get new devices and drugs to market.
Founded in late 2019, Basil’s platform leverages machine-learning across product, market and regulatory data to provide analytics and insights that guide strategic product development decisions, improve product performance and supply chain management, mitigate recall risks, and significantly reduce regulatory approval times.